Vertex Pharmaceuticals forecast annual revenue largely above Wall Street estimates on Monday, banking on robust sales of its ...
Greater pain intensity in cancer survivors correlates with increased cigarette, e-cigarette, and cannabis use, but decreased alcohol consumption. Greater pain intensity in cancer survivors has been ...
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
In a recent study, majority non-White communities had at least 40 percent lower mean adjusted per-capita distribution than majority White communities.
Experiencing pain may increase the odds that cancer survivors will use cigarettes and cannabis, according to a recent study published by Wiley online in CANCER.
U.S. Senators propose the Alternatives to PAIN Act to increase access to non-opioid pain treatments for seniors.
Their report on the Fentanyl Accountability and Prevention Act was designed to inform future decision-making...and "that ...
The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...
Medicare needs to cover non-opioid treatments instead of riskier ones. A new legislative proposal can help cover the cost.
3d
WSYR Syracuse on MSNNewly FDA-approved non-opioid painkiller is first of its kind in over 20 yearsFor the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
Why are CRISPR companies not OK? Will Robert F. Kennedy Jr. keep his promises if he's confirmed to lead the Department of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results